HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Temporal analysis of paracetamol-induced hepatotoxicity.

Abstract
Paracetamol-induced hepatotoxicity (APAP) causes severe damage that may be irreversible. Understanding the evolution of liver injury caused by overdose of the drug is important to assist in the treatment. In the present study, we evaluated the acute intoxication by APAP (500 mg/kg) in periods of 3 and 12 hours in C57BL/6 mice through biochemical, histological, inflammatory parameters, and the redox status. The results showed that in the 3-hour period there was an increase in creatinine dosage and lipid peroxidation (TBARS) compared to the control group. In the period of 12 hours after APAP intoxication all parameters evaluated were altered; there was an increase of ALT, AST, and necrosis, besides the increase of redox status biomarkers as carbonylated protein, TBARS, and MMP-9. We also observed activation of the inflammasome pathway as well as a reduction in the regenerative capacity of hepatocytes with a decrease in binucleated liver cells. In cytochrome gene expression, the mRNA level increased in CYP2E1 isoenzyme and reduced CYP1A2 expression. This study indicated that early treatment is necessary to mitigate APAP-induced acute liver injury, and alternative therapies capable of controlling the progression of intoxication in the liver are needed.
AuthorsAline Meireles Coelho, Isabela Ferreira Queiroz, Wanderson Geraldo Lima, André Talvani, Luiza Oliveira Perucci, Melina Oliveira de Souza, Daniela Caldeira Costa
JournalDrug and chemical toxicology (Drug Chem Toxicol) Vol. 46 Issue 3 Pg. 472-481 (May 2023) ISSN: 1525-6014 [Electronic] United States
PMID35313777 (Publication Type: Journal Article)
Chemical References
  • Acetaminophen
  • Thiobarbituric Acid Reactive Substances
Topics
  • Mice
  • Animals
  • Acetaminophen (toxicity)
  • Thiobarbituric Acid Reactive Substances (metabolism)
  • Chemical and Drug Induced Liver Injury (pathology)
  • Mice, Inbred C57BL
  • Liver

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: